• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall BioGenex

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 3 Device Recall BioGenexsee related information
Date Initiated by FirmSeptember 05, 2006
Date PostedSeptember 23, 2006
Recall Status1 Terminated 3 on November 17, 2006
Recall NumberZ-1519-06
Recall Event ID 36259
Product Classification Anti-CD 45 antibody - Product Code NJT
ProductAnti-CD45 Cocktail antibody in 6 ml vials; Cat. No. AM371-5M , manufactured and distributed by BioGenex, San Ramon, CA
Code Information Catalog Number AM371-5M, Lot number AM3710606, Expiration date June 2008.
FEI Number 2936532
Recalling Firm/
Manufacturer
Biogenex Laboratories
4600 Norris Canyon Road
San Ramon CA 94583-1320
Manufacturer Reason
for Recall
Mislabeling: Anti-CD45 cocktail antibody mislabeled as Ki-67.
FDA Determined
Cause 2
Other
ActionOn 9/5/06, the firm issued a notification letter to the consignees with a correct label to apply, and a return the reply form included with the letter.
Quantity in Commerce13 vials.
DistributionWorldwide distribution --- including state of Texas and countries of Amman, Jordan, and India.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 �7.55.
-
-